May 22, 2022

The Peggy Lillis Foundation, in coalition with 8 other organizations, recently penned an open letter to the US Food and Drug Administration (FDA) urging the agency’s increased involvement in the development of necessary recurrent C. diff infection treatments and preventatives. “We’ve seen what they could do during COVID-19. If they …

May 6, 2022

Peggy Lillis Foundation for C. diff Education and Advocacy convened the fourth annual C. diff Lobby Week April 4, 2022. 26 volunteers from PLF’s Board, Advocates Council and Scientific Advisory Council met with their members of Congress to advocate for C. diff awareness and improvements to health policy.  39 meetings …